Contemporary rules are designed to plot medicines less pricey for American seniors. But corporations warn innovation will suffer…
Read More
The Biden administration takes on the US treatment industry
Related Posts
Rising FII outflows can also now not be a injurious thing for Indian market, says Enam’s Manish Chokhani – Here’s why
Samvat 2080 has marked an unprecedented year for the Indian...
From finance to leisure, Adar Poonawalla’s gigantic bets in the last few years
From his dominance in vaccines and healthcare to his brave...
Stellapps secures $26 million in funding, targets pan-India expansion in dairy processing and cost added merchandise
The fresh capital infusion is poised to gasoline the firm’s...